These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6132880)

  • 1. Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.
    Cisar JO; Curl SH; Kolenbrander PE; Vatter AE
    Infect Immun; 1983 May; 40(2):759-65. PubMed ID: 6132880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.
    Cisar JO; Vatter AE; Clark WB; Curl SH; Hurst-Calderone S; Sandberg AL
    Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ; Vatter AE; Crowle AJ; Cisar JO
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.
    Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA
    Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a 95 kDa putative adhesin from Actinomyces serovar WVA963 strain PK1259 that is distinct from type 2 fimbrial subunits.
    Klier CM; Kolenbrander PE; Roble AG; Marco ML; Cross S; Handley PS
    Microbiology (Reading); 1997 Mar; 143 ( Pt 3)():835-846. PubMed ID: 9084167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and use of integration plasmids to generate site-specific mutations in the Actinomyces viscosus T14V chromosome.
    Yeung MK
    Infect Immun; 1995 Aug; 63(8):2924-30. PubMed ID: 7622214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of coaggregation-defective mutants of Actinomyces viscosus, Actinomyces naeslundii, and Streptococcus sanguis.
    Kolenbrander PE
    Infect Immun; 1982 Sep; 37(3):1200-8. PubMed ID: 7129635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservation of an Actinomyces viscosus T14V type 1 fimbrial subunit homolog among divergent groups of Actinomyces spp.
    Yeung MK
    Infect Immun; 1992 Mar; 60(3):1047-54. PubMed ID: 1347285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Immunol; 1981 Oct; 127(4):1318-22. PubMed ID: 6115881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the virulence-associated antigen on the surface fibrils of Actinomyces viscosus T14.
    Cisar JO; Vatter AE; McIntire FC
    Infect Immun; 1978 Jan; 19(1):312-9. PubMed ID: 624593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
    Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB
    Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes.
    Sandberg AL; Mudrick LL; Cisar JO; Brennan MJ; Mergenhagen SE; Vatter AE
    Infect Immun; 1986 Nov; 54(2):472-6. PubMed ID: 2876961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of Actinomyces viscosus mutants defective in binding salivary proline-rich proteins.
    Nesbitt WE; Beem JE; Leung KP; Clark WB
    Infect Immun; 1992 Mar; 60(3):1095-100. PubMed ID: 1347286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.
    Cisar JO; David VA; Curl SH; Vatter AE
    Infect Immun; 1984 Nov; 46(2):453-8. PubMed ID: 6150007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of a type 1 fimbrial subunit of Actinomyces viscosus T14V.
    Yeung MK; Chassy BM; Cisar JO
    J Bacteriol; 1987 Apr; 169(4):1678-83. PubMed ID: 2881922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of surface composition of Actinomyces viscosus T14V and T14AV.
    Powell JT; Fischlschweiger W; Birdsell DC
    Infect Immun; 1978 Dec; 22(3):934-44. PubMed ID: 730385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of bacterial adhesion in the oral cavity.
    Mergenhagen SE; Sandberg AL; Chassy BM; Brennan MJ; Yeung MK; Donkersloot JA; Cisar JO
    Rev Infect Dis; 1987; 9 Suppl 5():S467-74. PubMed ID: 2891180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34.
    Cisar JO; McIntire FC; Vatter AE
    Adv Exp Med Biol; 1978; 107():695-701. PubMed ID: 84522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
    Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ
    Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of serum antibody responses of inbred mice to type 1 and type 2 fimbriae from Actinomyces viscosus T14V.
    Haber J; Grinnell CM; Beem JE; Clark WB
    Infect Immun; 1991 Jul; 59(7):2364-9. PubMed ID: 1675628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.